Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Saccharomyces cerevisiae and Reduced Inflammation

Research synthesisLow evidenceModerate effect6 studies · 6 beneficial · 0 neutral · 0 harmful

Across 6 available studies, all report beneficial effects of Saccharomyces cerevisiae on inflammation, with predominantly moderate effect sizes. The strongest evidence comes from a small RCT (n=12) showing significant reductions in microvascular inflammation and irritation scores in healthy adults. Most studies used dried yeast fermentate, though doses and durations are not consistently reported.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 6 studies) — conclusions should be considered preliminary. Most studies are in vitro or animal models; only one small human RCT (n=12) supports the anti-inflammatory effect in humans, and many studies lack clear dose or form reporting.

Generated Jun 11, 2026
7 of 7 papers
Back to top